(RTTNews) - Wednesday, Madrigal Pharmaceuticals, Inc. (MDGL) announced its first-quarter financial results, reporting a net loss of $94.4 million, or $3.25 a share, compared to $73.2 million, or $2.61 a share, in the previous year.
Total operating expenses increased to $404.1 million from $216.6 million in the prior year.
Revenues amounted to $311.3 million compared to $137.3 million last year.
In the pre-market hours, MDGL is trading at $513.28, up 2.15 percent on the Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
